NCT00144274 - Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis | Biotech Hunter

Enrollment

220

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions

Pharyngitis

Interventions

DRUG

Ambroxol Lozenge

Trial Locations (12)

Boehringer Ingelheim Investigational Site, Boksburg

Boehringer Ingelheim Investigational Site, Midrand

Boehringer Ingelheim Investigational Site, Krugersdorp

Boehringer Ingelheim Investigational Site, Sandton

Boehringer Ingelheim Investigational Site, Johannesburg

Boehringer Ingelheim Investigational Site, Johannesburg

Boehringer Ingelheim Investigational Site, Durban

Boehringer Ingelheim Investigational Site, Cape Town

Boehringer Ingelheim Investigational Site, Cape Town

Boehringer Ingelheim Investigational Site, Cape Town

Boehringer Ingelheim Investigational Site, Pretoria

Boehringer Ingelheim Investigational Site, Pretoria